Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

A More Rapid Initial Decline of BCR::ABL1 Transcripts and Longer Treatment Duration with Improvement of Treatment-Free Remission Rate after Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Sewon Lee, Yeung-Chul Mun, Hongtae Kim, Sung-Ho Park, Semin Lee, Seunghoon Kim, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Yoonsung Lee, Dong-Wook Kim

Blood (2024) 144 (Supplement 1): 1779.

https://doi.org/10.1182/blood-2024-199242

Published: 2024

Journal Articles

Novel Chip-Based Digital Real-Time PCR Platform with Lab on an Array for the Sensitive Detection of BCR::ABL1 Transcripts in Chronic Myeloid Leukemia

Hyun-Woo Song, Sung-Hyun Kim, Young Rok Do, Kyung-Mi Ki, Soo Hyun Kim, Min-Sik Song, Seung-Shick Shin, Dong-Wook Kim

Blood (2024) 144 (Supplement 1): 6596.

https://doi.org/10.1182/blood-2024-206252

Published: 2024

Journal Articles

White Blood Cell Count, Neutrophil to Lymphocyte Ratio and Serum Lactate Dehydrogenase Level Associated with Thrombosis Risk Prediction in Essential Thrombocytosis

Yu Been Oh, Young Eun Lee, Ha Jin Lim, Yong Jun Kwon, Yong Jun Choi, Joo Heon Park, Hyun-Jung Choi, Hyun-Woo Choi, Seung-Jung Kee, Soo Hyun Kim, Jong Hee Shin, Myung Geun Shin

Blood (2024) 144 (Supplement 1): 6668.

https://doi.org/10.1182/blood-2024-202880

Published: 2024

Journal Articles

Highly Sensitive Chip-Based Digital PCR Platform for Quantitative Detection of BCR::ABL1 Transcripts throughout CML Treatment

Hyun-Woo Song, Sung-Hyun Kim, Young Rok Do, Kyung-Mi Ki, Soo Hyun Kim, Min-Sik Song, Seung-Shick Shin, Dong-Wook Kim

Blood (2023) 142 (Supplement 1): 1805.

https://doi.org/10.1182/blood-2023-185162

Published: 2023

Journal Articles

Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines

Young Eun Lee, Hye Ran Kim, Ha Jin Lim, Yong Jun Choi, Joo Heon Park, Hyun-Woo Choi, Hyun-Jung Choi, Seung-Jung Kee, Soo Hyun Kim, Jong Hee Shin, Chang Soo Park, Myung Geun Shin

Blood (2023) 142 (Supplement 1): 6034.

https://doi.org/10.1182/blood-2023-180448

Published: 2023

Journal Articles

Improvement of Treatment-Free Remission Rate Following Discontinuation of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Phase, Chronic Myeloid Leukemia

Sewon Lee, Hongtae Kim, Semin Lee, Seunghoon Kim, Sung-Ho Park, Sung-Hyun Kim, Young Rok Do, Soo-Hyun Kim, Kyung-Mi Kee, Dong-Wook Kim

Blood (2023) 142 (Supplement 1): 1806.

https://doi.org/10.1182/blood-2023-178408

Published: 2023

Journal Articles

Chip-Based Digital PCR Platform, Lab on an Array, the Newly Developed Highly Accurate and Sensitive Method for the Detection of BCR-ABL1 Transcripts in Chronic Myeloid Leukemia

Hyun-Woo Song, Kyung-Mi Ki, Soo Hyun Kim, Sung-Hyun Kim, Min-Sik Song, Do Young Lee, Seung-Shick Shin, Dong-Wook Kim

Blood (2022) 140 (Supplement 1): 3904–3905.

https://doi.org/10.1182/blood-2022-168020

Published: 2022

Journal Articles

Clinical Response Evaluation Toward Individualizing the Starting Dose of Dasatinib in Asian Patients with Chronic Myeloid Leukemia

Hyejin Shin, Jung-Eun Ha, Dae Young Zang, MDPhD, Sung-Hyun Kim, MD PhD, Young Rok Do, PhDMD, Won Sik Lee, MD PhD, Soo-Hyun Kim, Kyung-Mi Kee, Seon-Young Yang, So-Yoon Hwang, Eun-Jung Jang, Jangik Lee, PharmD, Dong-Wook Kim, MD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-140626

Published: 2020

Journal Articles

RNA Sequencing Based Whole Transcriptome Analysis Detected Precisely All Fusion Transcripts in Leukemias

Myung Geun Shin, MD PhD, Jun Hyung Lee, MD, Hyun Jung Choi, MD PhD, Seung Jung Kee, MD PhD, Soo Hyun Kim, MD PhD, Jong Hee Shin, MD PhD, Soon Pal Suh, MD PhD

Blood (2018) 132 (Supplement 1): 1496.

https://doi.org/10.1182/blood-2018-99-115785

Published: 2018

Journal Articles

Expression Status of Prohibitin Gene Predicts the Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics

Myung Geun Shin, MD PhD, Jun Hyung Lee, MD, Hye Ran Kim, PhD, Bo Ram Na, BS, Young Eun Lee, BS, Hyun Jung Choi, MD PhD, Soo Hyun Kim, MD PhD, Jong Hee Shin, MD PhD, Soon Pal Suh, MD PhD

Blood (2018) 132 (Supplement 1): 1497.

https://doi.org/10.1182/blood-2018-99-115726

Published: 2018

Journal Articles

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Blood (2018) 132 (9): 948–961.

https://doi.org/10.1182/blood-2018-02-832253

Published: 2018

Includes: Supplemental data

Journal Articles

Overexpression of Phospholipase C Beta 2 Is Associated with Favorable Prognosis in Normal Karyotype Acute Myeloid Leukemia

Jun Hyung Lee, MD MS, Hyun-Jung Choi, MD PhD, Soo-Hyun Kim, MD PhD, Jong-Hee Shin, MD PhD, Soon-Pal Suh, MD PhD, Myung-Geun Shin, MD PhD

Blood (2017) 130 (Supplement 1): 2677.

https://doi.org/10.1182/blood.V130.Suppl_1.2677.2677

Published: 2017

Journal Articles

Integrative Genomics Reveals Cancer Associated Mutations Are Common at Diagnosis of CML in Patients with Poor Response to TKI Therapy

Blood (2017) 130 (Supplement 1): 251.

https://doi.org/10.1182/blood.V130.Suppl_1.251.251

Published: 2017

Journal Articles

Mir-424 and Mir-503 Regulates Cobll1 Expression during the CML Progression

Seung Hun Han, PhD, Soo-Hyun Kim, Kim Hyoung-June, PhD, Lee Yoonsung, PhD, Soo-Young Choi, Park Gyeongsin, Kim Do-Hyun, Lee Aram, Kim Jongmin, PhD, Choi Je-Min, PhD, Kim Yonghwan, PhD, Myung Kyungjae, PhD, Kim Hongtae, PhD, Dong-Wook Kim, MD PhD

Blood (2017) 130 (Supplement 1): 4177.

https://doi.org/10.1182/blood.V130.Suppl_1.4177.4177

Published: 2017

Journal Articles

Diagnostic and Prognostic Implications of Prohibitin Overexpression in Normal Karyotype Acute Myeloid Leukemia

Hye-Ran Kim, PhD, Jun Hyung Lee, MD, Min-Gu Kang, MD, Ra-Young Park, PhD, Moinul Md Hoque, B.S., Sol Jeong, B.S., Min-Seo Noh, B.S., Seok-Yong Choi, MD, PhD, Soo-Hyun Kim, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2016) 128 (22): 1714.

https://doi.org/10.1182/blood.V128.22.1714.1714

Published: 2016

Journal Articles

Prevalence and Risk Predictive Factors of Comorbid Malignancies in Patients with Chronic Myeloid Leukemia

Tong-Yoon Kim, MD, Sung-Eun Lee, Soo-Hyun Kim, Soo-Young Choi, Eun-Jung Jang, Dong-Wook Kim, MD PhD

Blood (2016) 128 (22): 1900.

https://doi.org/10.1182/blood.V128.22.1900.1900

Published: 2016

Journal Articles

No Mutations of SF3B1 , U2AF1 , and SRSF2 spliceosomal Gene but Polymorphisms Associated with the Worse Prognosis in Multiple Myeloma

Min-Gu Kang, MD, Hye-Ran Kim, PhD, Jun Hyung Lee, MD, Thashma Pemmanda Ganapathy, M.S., Seung-Hyeon Yang, B.S., Moinul Hoque, B.S., Ra-Young Park, PhD, Seung Jung Kee, MD, PhD, Soo Hyun Kim, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Myung-Geun Shin, MD, PhD

Blood (2015) 126 (23): 4190.

https://doi.org/10.1182/blood.V126.23.4190.4190

Published: 2015

Journal Articles

Outcome of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Various Frontline Second-Generation Tyrosine Kinase Inhibitors: A Single-Center Experience

Sung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Hye-Young Song, Hea-Lyun Yoo, Mi-Young Lee, Ki-Hoon Kang, Hee-Jeong Hwang, Eun-Jung Jang, Dong-Wook Kim

Blood (2015) 126 (23): 1595.

https://doi.org/10.1182/blood.V126.23.1595.1595

Published: 2015

Journal Articles

BCR-ABL1 Transcript of 7.93% at 3 Months Is an Early Predictor for Long-Term Survival to Second-Line Therapy Using Next Generation Tyrosine Kinase Inhibitors in Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia

Sung-Eun Lee, Soo Young Choi, Yun Jeong Oh, Soo-Hyun Kim, Hye-Young Song, Hea-Lyun Yoo, Mi-Young Lee, Moon-Jung Chae, Ki-Hoon Kang, Hee-Jeong Hwang, Eun-Jung Jang, Dong-Wook Kim, MD PhD

Blood (2014) 124 (21): 4564.

https://doi.org/10.1182/blood.V124.21.4564.4564

Published: 2014

NARROW

A More Rapid Initial Decline of BCR::ABL1 Transcripts and Longer Treatment Duration with Improvement of Treatment-Free Remission Rate after Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Novel Chip-Based Digital Real-Time PCR Platform with Lab on an Array for the Sensitive Detection of BCR::ABL1 Transcripts in Chronic Myeloid Leukemia

White Blood Cell Count, Neutrophil to Lymphocyte Ratio and Serum Lactate Dehydrogenase Level Associated with Thrombosis Risk Prediction in Essential Thrombocytosis

Highly Sensitive Chip-Based Digital PCR Platform for Quantitative Detection of BCR::ABL1 Transcripts throughout CML Treatment

Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines

Improvement of Treatment-Free Remission Rate Following Discontinuation of BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Phase, Chronic Myeloid Leukemia

Chip-Based Digital PCR Platform, Lab on an Array, the Newly Developed Highly Accurate and Sensitive Method for the Detection of BCR-ABL1 Transcripts in Chronic Myeloid Leukemia

Clinical Response Evaluation Toward Individualizing the Starting Dose of Dasatinib in Asian Patients with Chronic Myeloid Leukemia

RNA Sequencing Based Whole Transcriptome Analysis Detected Precisely All Fusion Transcripts in Leukemias

Expression Status of Prohibitin Gene Predicts the Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Overexpression of Phospholipase C Beta 2 Is Associated with Favorable Prognosis in Normal Karyotype Acute Myeloid Leukemia

Integrative Genomics Reveals Cancer Associated Mutations Are Common at Diagnosis of CML in Patients with Poor Response to TKI Therapy

Mir-424 and Mir-503 Regulates Cobll1 Expression during the CML Progression

Diagnostic and Prognostic Implications of Prohibitin Overexpression in Normal Karyotype Acute Myeloid Leukemia

Comparison of Molecular Kinetics after the First and Second Imatinib Discontinuation: Results from the KID Study

Prevalence and Risk Predictive Factors of Comorbid Malignancies in Patients with Chronic Myeloid Leukemia

No Mutations of SF3B1 , U2AF1 , and SRSF2 spliceosomal Gene but Polymorphisms Associated with the Worse Prognosis in Multiple Myeloma

Outcome of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Various Frontline Second-Generation Tyrosine Kinase Inhibitors: A Single-Center Experience

BCR-ABL1 Transcript of 7.93% at 3 Months Is an Early Predictor for Long-Term Survival to Second-Line Therapy Using Next Generation Tyrosine Kinase Inhibitors in Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only